[1] |
Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer[J]. CA Cancer J Clin,2021,71(3):264-279.
|
[2] |
Liu X, Wang S, Li J, et al. Regulatory effect of traditional Chinese medicines on signaling pathways of process from chronic atrophic gastritis to gastric cancer[J]. Chin Herb Med,2021,14(1):5-19.
|
[3] |
Kato M, Hayashi Y, Nishida T, et al. Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis[J]. J Gastroenterol Hepatol,2021,36(8):2083-2090.
|
[4] |
Yang H, Wei B, Hu B. Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer[J]. Inflamm Res,2021,70(10-12):1015-1026.
|
[5] |
李梦声, 韩中博. 胃癌的高危可控因素--幽门螺杆菌感染[J/CD]. 中华实验和临床感染病杂志(电子版),2023,17(3):145-150.
|
[6] |
刘文忠, 谢勇, 陆红, 等. 第五次全国幽门螺杆菌感染处理共识报告[J]. 胃肠病学,2017,22(6):346-360.
|
[7] |
Park JM, Han YM, Park YJ, et al. Dietary intake of walnut prevented Helicobacter pylori-associated gastric cancer through rejuvenation of chronic atrophic gastritis[J]. J Clin Biochem Nutr,2021,68(1):37-50.
|
[8] |
Jiang JY, Liu DJ, Liu MX. The protective effect of NF-κB signaling pathway inhibitor PDTC on mice with chronic atrophic gastritis[J]. Scand J Gastroenterol,2021,56(10):1131-1139.
|
[9] |
房静远, 杜奕奇, 刘文忠, 等. 中国慢性胃炎共识意见(2017年,上海)[J]. 胃肠病学,2017,22(11):670-687.
|
[10] |
Park SH, Kang MJ, Yun EH, et al. Epidemiology of gastric cancer in Korea: Trends in incidence and survival based on Korea Central Cancer Registry Data (1999-2019)[J]. J Gastric Cancer,2022,22(3):160-168.
|
[11] |
Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw,2022,20(2):167-192.
|
[12] |
李富林, 李雪, 彭代荣. 良性和恶性病因术后残胃黏膜组织学变化特征及幽门螺杆菌感染状况[J/CD]. 中华实验和临床感染病杂志(电子版),2020,14(03):253-257.
|
[13] |
Usui Y, Taniyama Y, Endo M, et al. Helicobacter pylori, Homologous-recombination genes, and gastric cancer[J]. N Engl J Med,2023,388(13):1181-1190.
|
[14] |
Koizumi Y, Ahmad S, Ikeda M, et al. Helicobacter pylori modulated host immunity in gastric cancer patients with S-1 adjuvant chemotherapy[J]. J Natl Cancer Inst,2022,114(8):1149-1158.
|
[15] |
Yan L, Chen Y, Chen F, et al. Effect of Helicobacter pylori eradication on gastric cancer prevention: Updated report from a randomized controlled trial with 26.5 years of follow-up[J]. Gastroenterology, 2022,163(1):154-162. e3.
|
[16] |
Xiang W, Wang R, Bai D, et al. Helicobacter pylori related gastric cancer screening and cost-effectiveness analysis: A hospital-based cross-sectional study (SIGES)[J]. Nutr Cancer,2022,74(8):2769-2778.
|
[17] |
Kodama M, Okimoto T, Mizukami K, et al. Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study[J]. J Gastroenterol Hepatol,2021,36(8):2210-2216.
|
[18] |
Senchukova MA, Tomchuk O, Shurygina EI. Helicobacter pylori in gastric cancer: Features of infection and their correlations with long-term results of treatment[J]. World J Gastroenterol,2021,27(37):6290- 6305.
|
[19] |
石瑞春, 雍海江, 李志勇, 等. 慢性萎缩性胃炎胃镜分型与幽门螺杆菌抗体分型关联性研究[J]. 临床和实验医学杂志,2022,21(19):2047-2051.
|
[20] |
Zhang X, Li C, Chen D, et al. H. pylori CagA activates the NLRP3 inflammasome to promote gastric cancer cell migration and invasion[J]. Inflamm Res,2022,71(1):141-155.
|
[21] |
Liatsos C, Papaefthymiou A, Kyriakos N, et al. Helicobacter pylori, gastric microbiota and gastric cancer relationship: Unrolling the tangle[J]. World J Gastrointest Oncol,2022,14(5):959-972.
|
[22] |
Obayashi Y, Kawano S, Sakae H, et al. Risk factors for gastric cancer after the eradication of Helicobacter pylori evaluated based on the background gastric mucosa: A propensity score-matched case-control study[J]. Intern Med,2021,60(7):969-976.
|
[23] |
Collatuzzo G, Pelucchi C, Negri E, et al. Exploring the interactions between Helicobacter pylori (Hp) infection and other risk factors of gastric cancer: A pooled analysis in the Stomach cancer Pooling (StoP) Project[J]. Int J Cancer,2021,149(6):1228-1238.
|
[24] |
刘庆华, 李真, 张晓伟, 等. 胃镜下病理改变与血清幽门螺杆菌抗体分型的关系分析[J]. 内科理论与实践,2022,17(4):313-316.
|
[25] |
Ren S, Cai P, Liu Y, et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis[J]. J Gastroenterol Hepatol,2022,37(3):464-470.
|